| 摘要 |
PCT No. PCT/AU92/00332 Sec. 371 Date Mar. 15, 1994 Sec. 102(e) Date Mar. 15, 1994 PCT Filed Jul. 3, 1992 PCT Pub. No. WO93/01211 PCT Pub. Date Jan. 21, 1993The present invention provides peptides which have the ability to abrogate TNF toxicity and/or LPS toxicity. The present invention further relates to compositions including these peptides as the active ingredient and methods of anti-inflammatory treatment involving the administration of this composition. The peptides of the present invention are based primarily on residue 1 to 26 of human TNF. |
